Pharmacovigilance is the science and practice of monitoring the safety of medicines throughout their lifecycle, from clinical trials to post-market use. It focuses on detecting, assessing, understanding, and preventing adverse effects or other drug-related problems. Effective pharmacovigilance systems protect public health by ensuring that the benefits of a medicine outweigh its risks. With the rise of biologics, combination therapies, and global drug distribution, robust safety monitoring is more important than ever. Digital health tools, big data analytics, and real-world evidence are enhancing early detection of safety signals. Collaboration between regulatory agencies, healthcare providers, and the pharmaceutical industry is essential to maintain patient safety.
Subtracts:
Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)
Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
